Dr. William H. Farland is the
Director of the U.S. Environmental Protection Agency's (EPA)
National Center for Environmental Assessment which has major
responsibility for the conduct of chemical specific risk
assessments in support of EPA regulatory programs, the
development of Agency-wide guidance on risk assessment, and
the conduct of research to improve risk assessment. He has
served in this position since 1988. Prior to his selection
as Office Director, Dr. Farland served as the Director,
Carcinogen Assessment Group and Acting Director,
Reproductive Effects Assessment Group. Dr. Farland began his
EPA career in 1979 as a Health Scientist in the EPA's Office
of Toxic Substances. Dr. Farland's career has been
characterized by a commitment to the development of national
and international approaches to the testing and assessment
of the fate and effects of environmental agents. He
currently leads the Agency's multi-year effort to reassess
dioxin and related compounds.
Dr. Farland holds a Ph.D. (1976) from UCLA in Cell Biology
and Biochemistry, a M.A. (1972) in Zoology from the same
institution and a B.S. (1970) from Loyola University, Los
Angeles. He was awarded an Individual National Research
Service Award from the National Cancer Institute to pursue
postdoctoral training in DNA Damage and Repair at the
University of California, Irvine and at Brookhaven National
Laboratory.
Dr. Farland serves on a number of committees and advisory
boards. Within the Federal government he is a member of the
National Toxicology Program's (NTP) Executive Committee, EPA
Liaison to the Public Health Service Committee to Coordinate
Environmental Health and Related Programs (CCEHRP) past
Executive Secretary of the Federal Coordinating Council on
Science Engineering and Technology's Ad Hoc Working Group on
Risk Assessment and co-chair of the Committee on Life
Sciences and Health's Subcommittee on Risk Assessment. He is
also currently serves on the Office of Science and
Technology's Committee on Environment and Natural Resources'
(CENR) Risk Assessment Subcommittee. Dr. Farland served as
co-chair of the Federal Liaison Group (FLG) to the National
Academy of Sciences Committee on Risk Assessment Methods
(CRAM). He is also a member of the Science Advisory Panel of
the Chemical Industry Institute of Toxicology (CIIT), a
member of the Science Advisory Panel on EMF Research at the
Electric Power Research Institute (EPRI), and a member of
the Purdue University Dioxin Research Advisory Panel. He has
been a member of the Editorial Board for Risk
Analysis since 1987.
|